The Ottawa Hospital - Civic Campus
Ottawa, Ontario, K1Y 4E9, Canada
NCT Number: NCT00911677
Patients with the APOE-ε4 genotype are at increased risk of both vascular dementia and peripheral vascular disease. Patients undergoing major vascular surgery are at particularly high risk of delirium and other, more subtle, changes in cognitive function following surgery. The hypothesis of this trial is that the APOE-ε4 genotype is associated with both delirium and postoperative cognitive dysfunction (POCD).
Looking for future studies?
Notify Me60 year and older
All sexes
Observational
Ottawa, Ontario, K1Y 4E9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 days postoperatively
Time frame: 7 days postoperatively
Time frame: 3 months postoperatively
Ottawa Hospital Research Institute
Other
Does Apolipoprotein E Genotype Predict Delirium and Postoperative Cognitive Dysfunction?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02662257
Cognition Disorders, Cognitive Dysfunction
Beijing, Beijing Municipality, China
View Trial DetailsNCT02045004
Brain Diseases, Central Nervous System Diseases
Basel, Switzerland
View Trial DetailsNCT02964221
Cognition Disorders, Cognitive Change
View Trial DetailsNCT03133858
Cognition Disorders, Cognitive Dysfunction
Berlin, Germany
View Trial Details